Pegzilarginase

培齐拉酶

Report date: 2026/03/04 20:01:44

Base Information

Drug NamePegzilarginase
Drug Alias NameAERaseCo-ArgI-PEG(Aeglea Biotherapeutics)Pegarginase(Aeglea Biotherapeutics)PEG-arginase(Aeglea Biotherapeutics)Co-ArgI-PEG modified human arginase I(Aeglea Biotherapeutics) +[9] 
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionArginase replacements
TargetsArginine
Therapy Area/IndicationsHyperargininemiaSmall Cell Lung Carcinoma
Global Approved IndicationsHyperargininemia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2023/12/15
Country/TerritoryCanadaUnited StatesPuerto Rico +[9] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAeglea Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAeglea Biotherapeutics IncImmedica Pharma Ab
Inactive CompaniesN/A
Active IndicationsHyperargininemia
Inactive IndicationsSmall Cell Lung Carcinoma

Other Information

ATC CodeN/A
Related LinksN/A